Michael Asger Andersen
  • About
    • Contact
  • Publications
  • Teaching
  • Projects

Projects

Current research projects

Project Description Since
Pharmacogenomics in the Capital Region Implementing pre-emptive pharmacogenetic testing at Rigshospitalet for DPYD, TPMT/NUDT15, CYP2C19, and CYP2D6 to guide prescribing before treatment initiation. 2025
VISION-TDM Measuring whether therapeutic drug monitoring of ibrutinib and venetoclax reduces toxicity and improves efficacy in patients with chronic lymphocytic leukaemia. Funded by the Danish Cancer Society. 2024
SAMSON-2 Multicenter N-of-1 trial testing whether SLCO1B1 genotype predicts statin-associated muscle symptoms. Funded by the Capital Region of Denmark. 2024
No matching items
Michael Asger Andersen ©